Gerresheimer has announced that it intends to close its glass plant in Millville, NJ, this summer, with a loss of 140 jobs.
Gerresheimer AG, the Germany-based drug packaging company, said it is laying off 140 workers and shuttering its Millville, NJ, glass operation this summer.
The move is part of a companywide effort to consolidate its manufacturing operations in North America in response to declining customer accounts and a soft market. The plant let go of more than 100 workers earlier this year.
The business slowdown is likely connected to the FDA’s crackdown on manufacturing plants. About 22% of Gerresheimer’s sales come from the US. Though the company hasn’t said which of its clients have been affected by the stronger regulatory enforcement, one of its customers is Hospira which has been a target of the FDA for several years.